IPO - Microbot Medical Inc.

Form Type: S-1/A

Filing Date: 2025-02-10

Corporate Action: Ipo

Type: New

Accession Number: 000149315225005688

Filing Summary: Microbot Medical Inc. has filed an amendment to their registration statement under the Securities Act of 1933, indicating an IPO of common stock. This registration statement includes details about the costs associated with the issuance, which totals approximately $35,000, breaking down into SEC registration fees, legal fees, accounting fees, and other miscellaneous expenses. As of now, the company is a smaller reporting company and does not plan to use the extended transition period for complying with new accounting standards. Notably, the document encompasses a series of recent unregistered securities sales and various expenses related to the offering, alongside an overview of indemnification provisions for directors and officers, which are set in accordance with Delaware law. Additionally, corporate governance structures include agreements for indemnification with executives, reflecting the company's intent to safeguard its leadership. Furthermore, it notes that they are in compliance with relevant exemptions under the Securities Act for issued common stock during the past years.

Document Link: View Document

Form Type: S-1

Filing Date: 2025-02-04

Corporate Action: Ipo

Type: New

Accession Number: 000149315225004863

Filing Summary: Microbot Medical Inc. filed an S-1 registration statement with the SEC on February 4, 2025, in anticipation of an initial public offering (IPO). The filing outlines the company's business model, which focuses on developing innovative medical technologies, particularly robots for minimally invasive procedures. Key financial data, company management, and potential risks associated with the IPO are detailed within the document. The registration statement is a crucial step for Microbot Medical to offer its shares to the public and raise capital needed for its growth and product development.

Document Link: View Document

Form Type: 424B5

Filing Date: 2025-01-10

Corporate Action: Ipo

Type: New

Accession Number: 000149315225001556

Filing Summary: Microbot Medical Inc. is offering 3,788,550 shares of its common stock at a price of $2.27 per share in a registered direct offering and concurrent private placement. The offering aims to raise approximately $8.6 million in gross proceeds, with an expected net proceeds of about $7.77 million after deducting estimated offering expenses. The placement agent for this offering is H.C. Wainwright & Co., LLC, which will receive a 7% fee on the gross proceeds. Additionally, in a separate private placement, unregistered series H preferred investment options to purchase 7,577,100 shares of common stock at an exercise price of $2.10 are being offered. This financing comes after recent developments including a 510(k) premarket submission to the FDA for the LIBERTY® Endovascular Robotic Surgical System and ongoing preclinical trials. The document outlines strategic funding moves to bolster ongoing development and commercialization of innovative robotic surgical devices.

Document Link: View Document